Cellectar Biosciences cellectarbiosciences.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1148)

Cellectar Therapeutics, formerly Novelos Therapeutics, is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs), with radioisotopes that destroy malignant cells. Cellectar's products' unique mechanism of action is based on selective accumulation and retention in malignant tumors and not normal cells.

Cellectar Therapeutics, formerly Novelos Therapeutics, is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine lipid-like molecule...Show all

Company (IPO / Went public)

Phone: 617-244-1616

Fax: 617-964-6331

One Gateway Center
Suite 504
Newton, 02458
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cellectar Biosciences $15.1M Apr 15, 2011
See all 12 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cellectar Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 22 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 12 competitors